Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Sanofi is replacing CEO Paul Hudson with Merck KGaA leader Belén Garijo, M.D., Ph.D., after a series of R&D setbacks at the French pharma. Hudson will end his six-year run at Sanofi’s helm Feb. 17, at which point Olivier Charmeil, executive vice president of general medicines, will step in as interim CEO until Garijo arrives April 29.
Resonate Group, an ambitious Nigerian indigenous company with global aspirations, that aligns her vision with strategic intent to provide innovative solutions and services in Oil & Gas, Maritime, Manufacturing, Finance, Steel, Healthcare, and Supply Chain sectors of the Nigerian economy...
